Antidépresseurs tricycliques pour le traitement des enfants et des adolescents atteints d'un trouble du spectre autistique
Tricyclic Antidepressants for Autism Spectrum Disorders (ASD) in Children and Adolescents
This online article, written in French, summarizes a research review conducted to determine whether tricyclic antidepressants (TCAs) can be used to treat autism symptoms, as well as challenging behaviors and co-occurring mental health conditions in autism.
The review found three studies using two TCAs (tianeptine and clomipramine) with people on the autism spectrum. Evidence of positive impacts was limited and sometimes contradictory, and side effects were reported. The article concludes that more research is required before TCAs can be recommended for use with people on the autism spectrum.
This resource is available in English, French, Portuguese, and Spanish.
Cochrane is a “global independent network of researchers, professionals, patients, carers, and people interested in health.” [Website] The network reviews evidence about health treatments.
This online article is in French
Is there a mistake in this record?
Please email us at email@example.com
ACT provides the resources gathered in the Autism Information Database as a service. We cannot guarantee the suitability or effectiveness of any of the resources listed. We caution all users to be critical consumers; see MedlinePlus Guide to Healthy Web Surfing. ACT reserves the right to remove or refuse a listing, at our discretion.